[1] Shafi SS, Radhakrishnan TR. Studies on biologically active heterocycles [J]. Indian J Heterocycl Chem, 1995, 52, 133-138. [2] Talar MB, Dejai SR, Sommanavar YS, et al. Synthesis and antimicrobial activity of 1, 2, 4-triaziles, 1, 3, 4-oxadiazoles, and 1, 3, 4-thiadiazoles [J]. Indian J Heterocycl Chem, 1996, 5, 215-218. [3] Maslat AO, Abussaud M, Tashtoush H. Synthesis, antibacterial, antifungal and geno-toxic activity of bis 1, 3, 4 oxadiazile derivatives [J]. Pol J Pharmacol, 2002, 54, 55-59. [4] Sherif A, Rostom F, Shalaby MA, et al. Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl )-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents [J]. Eur J Med Chem, 2003, 38, 959-974. [5] Omar FA, Mahfouz NM, Rahman MA. Design, synthesis, and antiinflammatory activity of some 1, 3, 4-oxadiazole derivatives [J]. Eur J Med Chem, 1996, 31, 819-825. [6] Yu JX, Zhang SN, Li ZJ, et al. Synthesis, X-ray diffraction, and NMR analysis of (2S, 3a'R, 6'S, 7a'R)-3-acetyl-2', 2', 2'', 2''- tetramethyl-5-phenyl-2, 3-dihydro-1, 3, 4-oxadiazole-2-spiro-7'- (1', 3'-dioxanyl [4, 5-c] pyranyl)-6'-spiro-4''- (1'', 3''- dioxane) [J]. J Carbohydr Chem, 2001, 20 (9), 877-884. [7] Li ZJ, Zhang SN, Yu JX, et al. A species of spiro-fructose derivatives withantitumor activities. Chinese Pattent Application [P]. 2005, CN 1530371A. |